Modulation of the fecal bile acid profile by gut microbiota in cirrhosis.

[1]  P. Hylemon,et al.  Colonic mucosal microbiome differs from stool microbiome in cirrhosis and hepatic encephalopathy and is linked to cognition and inflammation. , 2012, American journal of physiology. Gastrointestinal and liver physiology.

[2]  H. Nittono,et al.  Detection of Δ4-3-oxo-steroid 5β-reductase deficiency by LC-ESI-MS/MS measurement of urinary bile acids. , 2012, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[3]  H. Sokol,et al.  Increase in fecal primary bile acids and dysbiosis in patients with diarrhea‐predominant irritable bowel syndrome , 2012, Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society.

[4]  S. Taylor-Robinson,et al.  A longitudinal systems biology analysis of lactulose withdrawal in hepatic encephalopathy , 2012, Metabolic Brain Disease.

[5]  C. Hofmann,et al.  Intestinal bacterial translocation in rats with cirrhosis is related to compromised paneth cell antimicrobial host defense , 2012, Hepatology.

[6]  Yunwei Wang,et al.  Dietary fat-induced taurocholic acid production promotes pathobiont and colitis in IL-10−/− mice , 2012, Nature.

[7]  Tetsuya Hayashi,et al.  Bile acid is a host factor that regulates the composition of the cecal microbiota in rats. , 2011, Gastroenterology.

[8]  H. Dupont,et al.  A randomized, double-blind, pilot study of rifaximin 550 mg versus placebo in the prevention of travelers' diarrhea in Mexico during the dry season. , 2011, Journal of travel medicine.

[9]  Baoli Zhu,et al.  Characterization of fecal microbial communities in patients with liver cirrhosis , 2011, Hepatology.

[10]  E. Want,et al.  Systemic gut microbial modulation of bile acid metabolism in host tissue compartments , 2010, Proceedings of the National Academy of Sciences.

[11]  N. Ajami,et al.  Bile Acids Improve the Antimicrobial Effect of Rifaximin , 2010, Antimicrobial Agents and Chemotherapy.

[12]  U. Beuers,et al.  Bile salts and cholestasis. , 2010, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

[13]  M. Merli,et al.  Peripheral and Splanchnic Indole and Oxindole Levels in Cirrhotic Patients: A Study on the Pathophysiology of Hepatic Encephalopathy , 2010, The American Journal of Gastroenterology.

[14]  A. Keshavarzian,et al.  Quantitative Assessment of the Human Gut Microbiome Using Multitag Pyrosequencing , 2010, Chemistry & biodiversity.

[15]  C. Leevy,et al.  Rifaximin treatment in hepatic encephalopathy. , 2010, The New England journal of medicine.

[16]  H. Dupont,et al.  Rifaximin-induced alteration of virulence of diarrhoea-producing Escherichia coli and Shigella sonnei. , 2010, International journal of antimicrobial agents.

[17]  A. Gasbarrini,et al.  Intestinal Permeability in Cirrhotic Patients With and Without Spontaneous Bacterial Peritonitis: Is the Ring Closed? , 2010, The American Journal of Gastroenterology.

[18]  H. Dupont,et al.  Pretreatment of Epithelial Cells with Rifaximin Alters Bacterial Attachment and Internalization Profiles , 2009, Antimicrobial Agents and Chemotherapy.

[19]  P. Tandon,et al.  Bacterial infections, sepsis, and multiorgan failure in cirrhosis. , 2008, Seminars in liver disease.

[20]  A. Yokota,et al.  Mechanism of Growth Inhibition by Free Bile Acids in Lactobacilli and Bifidobacteria , 2006, Journal of bacteriology.

[21]  Dae-Joong Kang,et al.  Bile salt biotransformations by human intestinal bacteria Published, JLR Papers in Press, November 18, 2005. , 2006, Journal of Lipid Research.

[22]  S. Riordan,et al.  Synbiotic modulation of gut flora: Effect on minimal hepatic encephalopathy in patients with cirrhosis , 2004, Hepatology.

[23]  L. Swell,et al.  Cholic acid synthesis as an index of the severity of liver disease in man , 1973, Gut.

[24]  L. Swell,et al.  Abnormal metabolism of secondary bile acids in patients with cirrhosis 1 , 1970, Gut.

[25]  P. Hylemon,et al.  Linkage of gut microbiome with cognition in hepatic encephalopathy. , 2012, American journal of physiology. Gastrointestinal and liver physiology.

[26]  K. Verbeke,et al.  Functional analysis of colonic bacterial metabolism: relevant to health? , 2012, American journal of physiology. Gastrointestinal and liver physiology.